Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
IntroductionPROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Preface

Takeo Fukushima
Anticancer Research August 2020, 40 (8) 4653;
Takeo Fukushima
Ph.D. & M.D.
Roles: President of the Society of Biotherapeutic Approaches (SBA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This special issue of ANTICANCER RESEARCH presents the Proceedings of the 23rd Annual Meeting of the Society of Biotherapeutic Approaches. It is our great pleasure to introduce this issue expressing my sincere gratitude to the Editors of Anticancer Research for kindly accepting and publishing the proceedings of our regional meeting in Japan in ANTICANCER RESEARCH.

The 23rd meeting was held in Niigata, Japan on December 7, 2019, chaired by Professor Masayuki Nashimoto, Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Science, Japan and Director Hiroshi Terada, Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Science, Japan. One of the highlights in this conference was the special lecture on “History of macrophage research” presented by Honorary professor Makoto Naito, Niigata University, Japan. In addition, there were many oral presentations on a wide range of basic and clinical topics, offering impressive advances in this field.

The main aims of our Society are to facilitate good communication between basic researchers and clinicians, and to perform clinical trials with adequate informed consent in an appropriate and professional manner. These aspects include important issues for the progress of biotherapy, as well as for medicine in general. It is our sincere hope that these Proceedings will contribute to further progress in the field of biotherapy and that our members will continue to foster the aims of our Society.

  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preface
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Preface
Takeo Fukushima
Anticancer Research Aug 2020, 40 (8) 4653;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Preface
Takeo Fukushima
Anticancer Research Aug 2020, 40 (8) 4653;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

PROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

  • Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion
  • The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
  • Clinical Outcomes of Surgical Resection for Brain Metastases from Non-small Cell Lung Cancer
Show more PROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Preface

  • Preface
Show more Preface
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire